The Journal of Immunology, Vol 154, Issue 1 268-280, Copyright © 1995 by American Association of Immunologists

ARTICLES

Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro

G Franke-Ullmann, C Pfortner, P Walter, C Steinmuller, ML Lohmann-Matthes, L Kobzik and J Freihorst
Fraunhofer Institute for Toxicology and Molecular Research, Department of Immunology, Hannover, Germany.

Alveolar macrophages (AL) are the first line of defense against inhaled pathogens and are exposed to virus during the course of a respiratory syncytial virus (RSV) infection. Interference of virus with alveolar macrophage functions may contribute to the risk of acquiring secondary bacterial infections during or after respiratory tract infections with RSV or other viral agents. We studied whether murine AL get infected with RSV and whether they support viral replication in vitro. In addition, the effects of RSV on microbicidal and on immunoregulatory functions were examined. Only a subpopulation of AL expressed viral F proteins after exposure of these cells to RSV. Infected AL released only small amounts of infectious virus into the supernatant. The extent of virus replication in AL seemed to be dependent in part on the amount of IFN induced by the virus, as has been demonstrated by infection of lung tissue macrophages and AL in vitro. In general, RSV infection of pulmonary macrophages appeared to be abortive. Nevertheless, release of reactive oxygen intermediates, phagocytosis, and killing of protozoa were reduced in RSV-infected AL in comparison to noninfected AL. In contrast, RSV stimulated secretion of TNF-alpha, IL-1, and IL-6 in an infectious-dose dependent manner. Along with the increased cytokine release, accessory functions of AL were increased after RSV exposure. Thus, exposure of AL to RSV appeared to stimulate their immunoregulatory functions, whereas the microbicidal activity of these cells seemed to be severely diminished.

This article has been cited by other articles:

				M. S. Boukhvalova, G. A. Prince, and J. C. G. Blanco Respiratory Syncytial Virus Infects and Abortively Replicates in the Lungs in Spite of Preexisting Immunity J. Virol., September 1, 2007; 81(17): 9443 - 9450. [Abstract] [Full Text] [PDF]

				A. M. LeVine, J. Elliott, J. A. Whitsett, A. Srikiatkhachorn, E. Crouch, N. DeSilva, and T. Korfhagen Surfactant Protein-D Enhances Phagocytosis and Pulmonary Clearance of Respiratory Syncytial Virus Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 193 - 199. [Abstract] [Full Text] [PDF]

				C. Cianci, E. V. Genovesi, L. Lamb, I. Medina, Z. Yang, L. Zadjura, H. Yang, C. D'Arienzo, N. Sin, K.-L. Yu, et al. Oral Efficacy of a Respiratory Syncytial Virus Inhibitor in Rodent Models of Infection Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2448 - 2454. [Abstract] [Full Text] [PDF]

				P.S. McNamara, B.F. Flanagan, A.M. Selby, C.A. Hart, and R.L. Smyth Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis Eur. Respir. J., January 1, 2004; 23(1): 106 - 112. [Abstract] [Full Text] [PDF]

				P. M. Kaan and R. G. Hegele Interaction between Respiratory Syncytial Virus and Particulate Matter in Guinea Pig Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., June 1, 2003; 28(6): 697 - 704. [Abstract] [Full Text] [PDF]

				A. L. Lambert, F. S. Trasti, J. B. Mangum, and J. I. Everitt Effect of Preexposure to Ultrafine Carbon Black on Respiratory Syncytial Virus Infection in Mice Toxicol. Sci., April 1, 2003; 72(2): 331 - 338. [Abstract] [Full Text] [PDF]

				K. A. Marr, R. A. Carter, M. Boeckh, P. Martin, and L. Corey Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors Blood, December 15, 2002; 100(13): 4358 - 4366. [Abstract] [Full Text] [PDF]

				E. M. Ponnuraj, A. R. Hayward, A. Raj, H. Wilson, and E. A. F. Simoes Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine J. Gen. Virol., November 1, 2001; 82(11): 2663 - 2674. [Abstract] [Full Text] [PDF]

				L. H. Thomas, M. I. Y. Wickremasinghe, M. Sharland, and J. S. Friedland Synergistic Upregulation of Interleukin-8 Secretion from Pulmonary Epithelial Cells by Direct and Monocyte-Dependent Effects of Respiratory Syncytial Virus Infection J. Virol., September 15, 2000; 74(18): 8425 - 8433. [Abstract] [Full Text]

				M.W. RAZA, C.C. BLACKWELL, R.A. ELTON, and D.M. WEIR Bactericidal activity of a monocytic cell line (THP-1) against common respiratory tract bacterial pathogens is depressed after infection with respiratory syncytial virus J. Med. Microbiol., March 1, 2000; 49(3): 227 - 233. [Abstract] [Full Text] [PDF]